TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants.

Yogesh S Jethava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.